1. Cytomegalovirus viremia in HIV-exposed and HIV-unexposed infants in Malawi.
- Author
-
Giuliano, Marina, Pirillo, Maria Franca, Orlando, Stefano, Luhanga, Richard, Mphwere, Robert, Kavalo, Thom, Andreotti, Mauro, Amici, Roberta, Ciccacci, Fausto, Marazzi, Maria Cristina, and Floridia, Marco
- Subjects
- *
INFANTS , *HIV , *BIRTH weight , *VIREMIA , *ANTIRETROVIRAL agents , *CYTOMEGALOVIRUSES , *INFANT health - Abstract
In sub-Saharan Africa the great majority of infants acquire Cytomegalovirus (CMV) infection within the first year of life. Maternal long-term antiretroviral therapy (ART) has been suggested to reduce the rate of CMV acquisition in HIV-exposed infants. In the present study serum samples collected at 6 months of age from HIV-exposed and HIV-unexposed infants were analyzed for the presence of CMV DNA (with CMV positivity defined by levels of CMV DNA > 1000 UI/ml). Twenty out of 58 (34.5%) infants had CMV DNA > 1000 UI/ml. There was no difference in the prevalence of CMV viremia between HIV-exposed and -unexposed infants [33.3% (15/45) vs 38.5% (5/13), respectively, P = 0.488]. In the HIV-exposed group, mothers of CMV-negative infants had received a longer antiretroviral treatment before delivery in comparison to mothers of CMV-positive infants (28 vs 3 months, P = 0.187). No differences in weights and lengths at birth, and at 1, 6 and 12 months were observed between CMV-positive and CMV-negative infants. In this study, the prevalence of CMV viremia at six months of age was high in infants born to HIV-positive mothers receiving long-term ART, similar to that of HIV-unexposed infants. Considering the possible relevant impact of CMV on infant health, strategies for containment of the infection should be explored. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF